Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen - Summary - MDSpire
Advertisement
Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen
To validate CDO1/CELF4 gene methylation analysis for detecting endometrial intraepithelial neoplasia (EIN) and endometrial cancer (EC), and to compare its diagnostic efficacy using noninvasive cervical brushing cells (CBCs) vs. invasive diagnostic curettage (D&C) samples.
Key Findings:
31 out of 226 participants were diagnosed with EIN or EC.
CDO1, CELF4, and CISENDO methylation tests showed superior diagnostic capabilities compared to conventional markers.
Significant differences in ΔCt values of CDO1 and CELF4 were observed between patients with EIN or EC and those with benign lesions (P < 0.0001).
Strong positive correlation between CBC and D&C samples for methylated CDO1 (R = 0.86) and CELF4 tests (R = 0.78).
No statistically significant difference in diagnostic accuracy between CBC and D&C samples for the CISENDO test (P = 0.244).
CISENDO test achieved an AUC of 0.929 with D&C samples and 0.916 with CBC samples.
Interpretation:
Remove unsupported claims about accuracy.
Limitations:
Add any limitations mentioned in the source material.
Conclusion:
Revise to avoid unsupported claims about the promise of the testing method.
